NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Finnrick
Free Test
← Tesamorelin vendors

Shandong Aishi BiotechnologyTesamorelin

6 testslatest 17 Jun 2026$2.10/mg median
No contact channels found
Intelligence report21 pages · who runs this vendorMonitor this vendor24/7 safety alerts · Finnrick Gold
Free peptide testing

Ordered Tesamorelin from Shandong Aishi Biotechnology? Mail in a sample (US only) and let us test it for free.

Test my supply
+2 more ↓
48%
Finnrick rating
#50 of 106 Tesamorelin vendors
3 of 6 classifiable tests passed
customers 4.1★ (3)
methodology · Purity focus
Finnrick analysis · Tesamorelin

Volatile fill results drive a mixed reliability profile for this Tesamorelin, with a +36% overfill, -48% and -54% underfills, and one 99.1% purity miss. The latest lot rebounded, but evidence remains uneven.

methodology →
vendor intelligence report
Vendor Intelligence Report: Shandong Aishi Biotechnology

Registry records frame Shandong Aishi as a young sole-owner exporter, while TikTok presents a factory-grade production story. The report traces the ownership, claim gaps, DNS/contact stack, and unresolved penalty flags buyers cannot see from the live stats.

21 pages5 risk factors assessed3 Jul 2026
read the report
Peptides
10 rated · tap to focus
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.07
95%
16
2
Tirzepatide
$0.43
80%
30
3
Retatrutide
$0.93
79%
25
4
Ipamorelin
$1.96
75%
4
5
BPC-157
-
55%
3
6
Tesamorelinselected
$2.10
48%
6
7
HGH
-
38%
3
8
Cagrilintide
$4.40
-
0
9
MOTS-c
-
-
0
10
Semaglutide
$0.65
-
0
Rating trend
Tesamorelin from this vendor, after each test
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%11 Dec 2025: 24%2 Feb 2026: 33%4 Feb 2026: 37%20 Feb 2026: 38%27 May 2026: 45%17 Jun 2026: 48%29 Sep 2026: current 48%24%45%48%Dec 25Sep 26
Showing Tesamorelin tests only
Shandong Aishi Biotechnology Tesamorelin test history
6 tests · 3 pass · 3 fail
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
17 Jun 2026Pass
av4yfwn
Tested
lab nameView COA
27 May 2026Fail
uu3huvh
Tested
lab nameView COA
20 Feb 2026Fail
y5jw2fp
Tested
lab nameView COA
4 Feb 2026Pass
bj996th
Tested
lab nameView COA
2 Feb 2026Pass
z6ndyvv
Tested
lab nameView COA
11 Dec 2025Fail
nz3mhv7
Tested
lab nameView COA

About Shandong Aishi Biotechnology test results from Finnrick

Shandong Aishi Biotechnology is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 7 peptides and 87 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Shandong Aishi Biotechnology peptides in this dataset are BPC-157 (3 tests), GHK-Cu (16 tests) and HGH (3 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 87 recent tests.

Corrections
0 corrections
No corrections.
Free peptide testing

Ordered Tesamorelin from Shandong Aishi Biotechnology? Mail in a sample (US only) and let us test it for free.

Test my supply